At $2M, priciest ever medicine treats fatal genetic disease
U.S. regulators have approved the most expensive medicine ever, for a rare disorder that destroys a baby’s muscle control and kills nearly all of those...
Continue ReadingThermo Fisher Scientific inaugurates new facility in Ahmedabad
The state-of-the art facility in the domestic tariff area (DTA) is part of Thermo Fisher’s clinical trials business and was built to help address the...
Continue ReadingShilpa Medicare gets USFDA nod for cancer treatment injection
Shilpa Medicare said it has received approval from the US health regulator for Irinotecan HCL injection, used for treatment of certain kind of cancers. The company has...
Continue ReadingPhytotech Extracts invests Rs.12 crore for advanced phyto extracts unit in Karnataka to bolster its foray into global markets
Phytotech Extracts has invested Rs.12 crore via the self funded route for its new facility to foray into the global markets as a phyto extracts company....
Continue ReadingIndian generic industry loses a titan in DG Shah
D G Shah had a larger imprint on the pharma industry than what his job title — secretary general of the Indian Pharmaceutical Alliance (IPA)...
Continue ReadingFDA takes new steps to adopt more modern technologies for improving the security of the drug supply chain through innovations that improve tracking and tracing of medicines
A key element of the U.S. Food and Drug Administration’s mission is focused on helping to ensure that all products we regulate, including drugs available...
Continue ReadingGlenmark Pharma appoints CEO for its new innovation company
Glenmark Pharmaceuticals has announced the appointment of Alessandro Riva as the CEO of its new innovation company.Mr. Riva is currently Executive Vice President, Oncology Therapeutics...
Continue ReadingUS FDA chief’s exit could impact Indian pharma
The abrupt exit of the US FDA commissioner Scott Gottlieb after a nearly 2-year stint under the Trump administration throws Indian pharma into uncertainty on...
Continue ReadingIndia gets tough on generics quality issues and cancer drug prices
Even as more blood pressure drugs are being recalled in the USA after being found to contain trace amounts of a potentially cancer-causing ingredient, India’s...
Continue Reading
